Amarin’s Vascepa To Take Part In Covid-19 Study In Adults With Heart Disease
Biotech Amarin (AMRN) said that that the MITIGATE COVID-19 study, will test the effects of Vascepa on viral upper respiratory infection (URI) rates and …
Source: Amarin’s Vascepa To Take Part In Covid-19 Study In Adults With Heart Disease